Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
More Evidence Needed For Chiesi’s Ultra Orphan Lamzede, Says NICE
May 24 2018
•
By
Francesca Bruce
NICE not sure Chiesi's Lamzede is cost-effective • Source: Scrip archive
More from Rare Diseases
More from Scrip